ViiV Healthcare continues HIV care partnership with Chelsea and Westminster Hospital

Partnership aims to transform HIV patient care with digital services

Read on PharmaTimes

Xalkori bags FDA green light for rare paediatric non-Hodgkin lymphoma

Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma

Read on PharmaTimes

UK biotech Ixaka scores additional funding for cell and gene therapy research

Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia

Read on PharmaTimes

AZ, Daiichi Sankyo’s Enhertu wins US approval for HER2-positive gastric cancer

Approval is based on results from the Phase III DESTINY-Gastric01 trial

Read on PharmaTimes

Boehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies

Agreement will leverage Enara's novel Dark Antigen discovery platform

Read on PharmaTimes

1 2 3

Top of page

Industry News

Partnership aims to transform HIV patient care with digital services.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us